NCT04478318Active, not recruiting
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
Quantitative Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma Undergoing Standard-of-Care FDG-PET/CT for Initial Staging
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
To determine the minimum scan duration for fluorine-18 positron-emitting radioactive isotope-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) scans performed on a total-body PET/CT scanner that results in non-inferior image quality to 18F-FDG PET/CT scans performed on a conventional PET/CT scanner. The subject population will be patients being staged for lung cancer, lymphoma, or melanoma.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- First submitted
- 15 Jul 2020
- Start date
- 1 Jun 2020
- Primary completion date
- 17 Jul 2025
- Lead sponsor
- University of California, Davis
- Diseases
- Melanoma, Lung cancer
- NCT number
- NCT04478318
What you commit to
- Study type: Interventional
- Planned participants: 180
- From 1 Jun 2020 to the primary completion date, 17 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any significant medical condition that in the opinion of the investigator would prevent the subject from participating and/or adhering to study related procedures or interfere with subject safety.
Other
- Pregnant women.
- Claustrophobia.
Who the study is looking for
- Ability to understand and willingness to sign an informed consent form.
- Ability to adhere to the study visit schedule and all protocol requirements.
- Men and women ≥18 years of age.
- Diagnosis or suspected diagnosis of lung cancer, melanoma or lymphoma.
- Patients who have been referred for a PET/CT scan.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California - Davis Coordinator of this site? Confirm its status | Sacramento | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.